LobbyingEnhabit Home Health & Hospice lobbying by quarter
Enhabit Home Health & Hospice's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $80K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.
Enhabit Home Health & Hospice
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $80K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $40K | 1 |
| Q1 2023 | $90K | 1 |
| Q2 2023 | $120K | 1 |
| Q3 2023 | $135K | 1 |
| Q4 2023 | $145K | 1 |
| Q1 2024 | $90K | 1 |
| Q2 2024 | $80K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $80K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$910K · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseEnhabit Home Health & Hospice | $1M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| TYLER SHRIVE | Professional Health Staff - Sen. Lamar Alexander (TN)/Senate Health, Education, Labor, and Pensions Committee | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/08for Q2 | In-house | $30K |
| 03/31for Q1 | In-house | $30K |
| 01/06for Q4 2025 | In-house | $20K |
| 25/10/08for Q3 2025 | In-house | $20K |
| 25/08/05for Q2 2025 | In-house | $20K |
| 25/04/07for Q1 2025 | In-house | $20K |
| 25/01/06for Q4 2024 | In-house | $80K |
| 24/11/05for Q3 2024 | In-house | $80K |
| 24/07/23for Q2 2024 | In-house | $80K |
| 24/04/19for Q1 2024 | In-house | $90K |
| 24/01/23for Q4 2023 | In-house | $145K |
| 23/10/20for Q3 2023 | In-house | $135K |
| 23/07/20for Q2 2023 | In-house | $120K |
| 23/07/20for Q1 2023 | In-house | $90K |
| 23/07/17for Q2 2023 | In-house | Under $5,000 |
| 23/04/20for Q1 2023 | In-house | $30K |
| 23/01/20for Q4 2022 | In-house | $40K |